Overview

Mono Antiplatelet and Colchicine Therapy

Status:
Recruiting

Trial end date:
2022-06-13

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of aspirin-free, P2Y12 inhibitor single antiplatelet and colchicine treatment in patients with acute coronary syndrome treated with drug-eluting stents.

Phase:

Phase 4

Details

Lead Sponsor:

Wonkwang University Hospital

Treatments:

Aspirin
Colchicine